Abdominal wall metastasis of ovarian carcinoma after low transverse abdominal incision: report of two cases and review of literature

Int J Gynecol Cancer. 2006 Jan-Feb:16 Suppl 1:334-7. doi: 10.1111/j.1525-1438.2006.00511.x.

Abstract

Occurrence of parietal metastases after surgery for a suspect adnexal mass may worsen the prognosis of the disease. However, it is not clear whether abdominal wall metastases is related to specific biologic features or simply to surgical mismanagement involving small incisions and traumatic extraction of the specimen, resulting in direct seeding of cancer cells. We report two cases with development of parietal dissemination of ovarian carcinomas after Pfannenstiel incision. The two patients needed parietal resection to obtain optimal surgical cytoreduction. Pfannenstiel incisions for exploration of suspicious adnexal masses increase the risk of extensive parietal metastasis in case of malignancy because they require reflection of several sheaths of tissue. The parietal extension of the disease may need major parietal resection that can worsen the functional and general outcome of the patients.

MeSH terms

  • Abdominal Wall
  • Adenocarcinoma, Mucinous / drug therapy
  • Adenocarcinoma, Mucinous / secondary*
  • Adenocarcinoma, Mucinous / surgery
  • Adult
  • Antineoplastic Combined Chemotherapy Protocols / administration & dosage
  • Bleomycin / administration & dosage
  • Cisplatin / administration & dosage
  • Doxorubicin / administration & dosage
  • Etoposide / administration & dosage
  • Female
  • Granulosa Cell Tumor / drug therapy
  • Granulosa Cell Tumor / secondary*
  • Granulosa Cell Tumor / surgery
  • Gynecologic Surgical Procedures
  • Humans
  • Ifosfamide / administration & dosage
  • Middle Aged
  • Neoplasm Recurrence, Local / drug therapy
  • Neoplasm Recurrence, Local / surgery
  • Neoplasm Seeding*
  • Ovarian Neoplasms / drug therapy
  • Ovarian Neoplasms / pathology*
  • Ovarian Neoplasms / surgery
  • Paclitaxel / administration & dosage
  • Peritoneal Neoplasms / drug therapy
  • Peritoneal Neoplasms / secondary*
  • Peritoneal Neoplasms / surgery

Substances

  • Bleomycin
  • Etoposide
  • Doxorubicin
  • Paclitaxel
  • Cisplatin
  • Ifosfamide

Supplementary concepts

  • BEP protocol